SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1(neg)/CK7(pos)/HepPar-1(pos) immunophenotype.
about
SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1(neg)/CK7(pos)/HepPar-1(pos) immunophenotype.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
SMARCA4-deficient pulmonary ad ...... HepPar-1(pos) immunophenotype.
@en
type
label
SMARCA4-deficient pulmonary ad ...... HepPar-1(pos) immunophenotype.
@en
prefLabel
SMARCA4-deficient pulmonary ad ...... HepPar-1(pos) immunophenotype.
@en
P2093
P2860
P1433
P1476
SMARCA4-deficient pulmonary ad ...... HepPar-1(pos) immunophenotype.
@en
P2093
Abbas Agaimy
Arndt Hartmann
Evgeny A Moskalev
Florian Fuchs
Florian Haller
Horia Sirbu
P2860
P2888
P356
10.1007/S00428-017-2148-5
P577
2017-05-30T00:00:00Z